PDA

View Full Version : Medscape

Pages : 1 2 3 [4] 5 6 7 8 9
  1. Temsirolimus Is Effective for Metastatic Renal Cell Carcinoma
  2. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  3. New Guidelines Issued for Nervous System Lyme Disease
  4. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  5. FDA Safety Changes: Keppra, Saizen, Prozac
  6. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  7. New Breast Cancer Susceptibility Genes Identified
  8. Temsirolimus Is Effective for Metastatic Renal Cell Carcinoma
  9. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  10. New Guidelines Issued for Nervous System Lyme Disease
  11. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  12. FDA Safety Changes: Keppra, Saizen, Prozac
  13. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  14. New Breast Cancer Susceptibility Genes Identified
  15. Temsirolimus Is Effective for Metastatic Renal Cell Carcinoma
  16. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  17. New Guidelines Issued for Nervous System Lyme Disease
  18. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  19. FDA Safety Changes: Keppra, Saizen, Prozac
  20. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  21. New Breast Cancer Susceptibility Genes Identified
  22. Temsirolimus Is Effective for Metastatic Renal Cell Carcinoma
  23. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  24. New Guidelines Issued for Nervous System Lyme Disease
  25. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  26. FDA Safety Changes: Keppra, Saizen, Prozac
  27. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  28. New Breast Cancer Susceptibility Genes Identified
  29. Temsirolimus Is Effective for Metastatic Renal Cell Carcinoma
  30. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  31. New Guidelines Issued for Nervous System Lyme Disease
  32. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  33. FDA Safety Changes: Keppra, Saizen, Prozac
  34. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  35. New Breast Cancer Susceptibility Genes Identified
  36. Temsirolimus Is Effective for Metastatic Renal Cell Carcinoma
  37. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  38. New Guidelines Issued for Nervous System Lyme Disease
  39. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  40. FDA Safety Changes: Keppra, Saizen, Prozac
  41. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  42. New Breast Cancer Susceptibility Genes Identified
  43. Temsirolimus Is Effective for Metastatic Renal Cell Carcinoma
  44. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  45. New Guidelines Issued for Nervous System Lyme Disease
  46. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  47. FDA Safety Changes: Keppra, Saizen, Prozac
  48. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  49. New Breast Cancer Susceptibility Genes Identified
  50. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  51. New Guidelines Issued for Nervous System Lyme Disease
  52. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  53. FDA Safety Changes: Keppra, Saizen, Prozac
  54. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  55. New Breast Cancer Susceptibility Genes Identified
  56. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  57. New Guidelines Issued for Nervous System Lyme Disease
  58. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  59. FDA Safety Changes: Keppra, Saizen, Prozac
  60. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  61. New Breast Cancer Susceptibility Genes Identified
  62. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  63. New Guidelines Issued for Nervous System Lyme Disease
  64. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  65. FDA Safety Changes: Keppra, Saizen, Prozac
  66. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  67. New Breast Cancer Susceptibility Genes Identified
  68. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  69. New Guidelines Issued for Nervous System Lyme Disease
  70. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  71. FDA Safety Changes: Keppra, Saizen, Prozac
  72. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  73. New Breast Cancer Susceptibility Genes Identified
  74. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  75. New Guidelines Issued for Nervous System Lyme Disease
  76. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  77. FDA Safety Changes: Keppra, Saizen, Prozac
  78. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  79. New Breast Cancer Susceptibility Genes Identified
  80. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  81. New Guidelines Issued for Nervous System Lyme Disease
  82. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  83. FDA Safety Changes: Keppra, Saizen, Prozac
  84. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  85. New Breast Cancer Susceptibility Genes Identified
  86. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  87. New Guidelines Issued for Nervous System Lyme Disease
  88. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  89. FDA Safety Changes: Keppra, Saizen, Prozac
  90. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  91. New Breast Cancer Susceptibility Genes Identified
  92. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  93. New Guidelines Issued for Nervous System Lyme Disease
  94. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  95. FDA Safety Changes: Keppra, Saizen, Prozac
  96. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  97. New Breast Cancer Susceptibility Genes Identified
  98. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  99. New Guidelines Issued for Nervous System Lyme Disease
  100. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  101. FDA Safety Changes: Keppra, Saizen, Prozac
  102. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  103. New Breast Cancer Susceptibility Genes Identified
  104. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  105. New Guidelines Issued for Nervous System Lyme Disease
  106. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  107. FDA Safety Changes: Keppra, Saizen, Prozac
  108. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  109. New Breast Cancer Susceptibility Genes Identified
  110. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  111. New Guidelines Issued for Nervous System Lyme Disease
  112. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  113. FDA Safety Changes: Keppra, Saizen, Prozac
  114. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  115. New Breast Cancer Susceptibility Genes Identified
  116. Time Watching Television Linked to Glucose Control in Pediatric Type 1 Diabetes
  117. New Guidelines Issued for Nervous System Lyme Disease
  118. Exposure to Pesticides Linked to Risk for Parkinson's Disease
  119. FDA Safety Changes: Keppra, Saizen, Prozac
  120. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  121. New Breast Cancer Susceptibility Genes Identified
  122. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  123. New Breast Cancer Susceptibility Genes Identified
  124. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  125. New Breast Cancer Susceptibility Genes Identified
  126. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  127. New Breast Cancer Susceptibility Genes Identified
  128. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  129. New Breast Cancer Susceptibility Genes Identified
  130. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  131. New Breast Cancer Susceptibility Genes Identified
  132. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  133. New Breast Cancer Susceptibility Genes Identified
  134. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  135. New Breast Cancer Susceptibility Genes Identified
  136. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  137. New Breast Cancer Susceptibility Genes Identified
  138. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  139. New Breast Cancer Susceptibility Genes Identified
  140. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  141. New Breast Cancer Susceptibility Genes Identified
  142. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  143. New Breast Cancer Susceptibility Genes Identified
  144. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  145. New Breast Cancer Susceptibility Genes Identified
  146. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  147. New Breast Cancer Susceptibility Genes Identified
  148. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  149. New Breast Cancer Susceptibility Genes Identified
  150. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  151. New Breast Cancer Susceptibility Genes Identified
  152. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  153. New Breast Cancer Susceptibility Genes Identified
  154. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  155. New Breast Cancer Susceptibility Genes Identified
  156. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  157. New Breast Cancer Susceptibility Genes Identified
  158. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  159. New Breast Cancer Susceptibility Genes Identified
  160. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  161. New Breast Cancer Susceptibility Genes Identified
  162. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  163. New Breast Cancer Susceptibility Genes Identified
  164. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  165. New Breast Cancer Susceptibility Genes Identified
  166. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  167. New Breast Cancer Susceptibility Genes Identified
  168. DSM-IV Diagnostic Criteria for Eating Disorders May Be Too Stringent
  169. New Breast Cancer Susceptibility Genes Identified
  170. New Breast Cancer Susceptibility Genes Identified
  171. New Breast Cancer Susceptibility Genes Identified
  172. New Breast Cancer Susceptibility Genes Identified
  173. New Breast Cancer Susceptibility Genes Identified
  174. New Breast Cancer Susceptibility Genes Identified
  175. New Breast Cancer Susceptibility Genes Identified
  176. New Breast Cancer Susceptibility Genes Identified
  177. New Breast Cancer Susceptibility Genes Identified
  178. New Breast Cancer Susceptibility Genes Identified
  179. New Breast Cancer Susceptibility Genes Identified
  180. New Breast Cancer Susceptibility Genes Identified
  181. New Breast Cancer Susceptibility Genes Identified
  182. Investigational Protease Inhibitor Rapidly Inhibits HCV RNA Replication
  183. FDA Device Clearances: Evicel, E Series, Carescape
  184. Vitamin A (Retinol) Effaces Wrinkles in Naturally Aged Skin
  185. Neonatal Intensive Care Reduces Mortality in Very-Low-Birth-Weight Infants
  186. Aggressive Care Might Delay Recovery From Whiplash
  187. Guidelines for Drug Dosing Regimens in Chronic Kidney Disease
  188. Chemotherapy Medication Errors Common in Children
  189. PSA Velocity Most Significant Predictor of Prostate Cancer Mortality
  190. Higher Production of IL-1 or TNF-alpha Linked to Increased AD Risk
  191. NYT Feature Looks at Lost Opportunities in Stroke Care
  192. Methylnaltrexone May Improve Postoperative Ileus After Segmental Colectomy
  193. Hospitalist Model May Reduce Costs Without Adversely Affecting Outcomes
  194. "Mini-Rounds" May Help Improve Physician-Patient Communication and Satisfaction
  195. Medication Discrepancies in Sign-Outs are Frequent and Potentially Harmful
  196. Smoke-Free Home Rules Increasing in United States
  197. First-Time Generic Approvals: Toprol-XL, Suprax, Lotrel
  198. Increased Coffee Consumption May Reduce Risk for Gout in Men
  199. Risk Factors Identified for Poor Short-Term Outcome in Acute Pediatric Asthma
  200. No Disadvantage Seen With Intermittent Androgen Suppression for Advanced Prostate Can
  201. Erectile Dysfunction Drugs Show Promise in Treatment of Lower Urinary Tract Symptoms
  202. Novel Drug Shows Strongly Positive Results in Irritable Bowel Syndrome With Constipat
  203. Salmeterol and Fluticasone Propionate Slow Decline in COPD Patients
  204. More Than 30% of US Stroke Survivors Receive Outpatient Rehabilitation
  205. Severe Worry, Below GAD, Can Impair Quality of Life in the Elderly
  206. Daily Breathing and Awakening Tests Speed Weaning From Mechanical Ventilation
  207. Surveys Show Extensive Drug-Resistant TB in New York City, India
  208. Bath Psoralen UV Therapy, Saltwater UV-B May Be Effective for Psoriasis
  209. ACE Inhibitors May Slow Progression of IgA Renal Disease
  210. Pulsed Radiofrequency Helpful for Herniated Disk and Spinal Stenosis
  211. FDA Approves Enoxaparin for STEMI
  212. Severity of Panic Disorder Similar in Smokers and Nonsmokers
  213. Computer Model Determines Efficient Strategies for Inoculating Hospital Staff in Pand
  214. Possible Role for MRI in Patients With Newly Diagnosed Breast Cancer
  215. Aspirin Prevents Only COX-2-Positive Colorectal Cancer
  216. Possible Role for MRI in Patients with Newly Diagnosed Breast Cancer
  217. Aspirin Prevents Only C0X-2-Positive Colorectal Cancer
  218. Fish-Oil Supplements Plus Regular Aerobic Exercise Benefit Overweight Patients
  219. Narrowband UV-B Treatment More Effective for Vitiligo Than Psoralen UV-A Therapy
  220. FDA Safety Changes: Cordarone, Genotropin, Noroxin
  221. Pubovaginal Fascial Sling May Be Helpful for Urinary Stress Incontinence in Women
  222. Incisionless Suturing Possible for Closure of GI Perforations
  223. FDA Approves Lybrel for Continuous Contraception
  224. Chronic Gum Disease May Increase Tongue Cancer Risk
  225. FDA Requests More Data for Prostate Cancer Vaccine
  226. Monitoring of Metabolic Adverse Effects From Antipsychotics Could Be Improved
  227. Temozolomide Effective Against Low-Grade Gliomas
  228. Flexible Sigmoidoscopy May Miss Colon Cancers in Highest-Risk Group
  229. AUA Updates Prostate Cancer Treatment Guidelines
  230. New Recommendations Issued for Treatment of Malaria in the United States
  231. Sleep Apnea Increases Risk for Diabetes
  232. Rescue Use of Beclomethasone, Albuterol in a Single Inhaler May Be Helpful for Mild A
  233. LHRH-Analogues Beneficial in Premenopausal Women With Hormone-Receptor-Positive Breas
  234. International Panel Updates Ureteral Stone Guidelines
  235. Newly Approved Nebulizer Formulation of Formoterol an Effective Bronchodilator
  236. FDA Device Clearances: Immulite, EMS Swiss Dolorclast, Cavity SpineWand
  237. New Biomarker May Provide Noninvasive Method for Assessing Nonalcoholic Fatty Liver D
  238. Prescriptions of Antidepressants for Bipolar Patients High, Despite Concerns
  239. New Biomarker May Provide Noninvasive Method for Assessing Nonalcoholic Fatty Liver D
  240. Moderate Alcohol Use May Slow Progression to Dementia
  241. Autologous Platelet Gel May Speed Wound Healing
  242. Antiplatelet Agents Reduce Risk for Preeclampsia
  243. Serum Phosphorus May Be a Marker for Cardiovascular Risk
  244. Inherited Genes Linked to Toxicity of Antileukemic Drugs
  245. Single Mid-Life PSA Measurement Predicts Prostate Cancer Risk
  246. Botox May Improve Idiopathic Detrusor Overactivity in Patients With Overactive Bladde
  247. International Approvals: Herceptin, Reyataz, and Peg-Intron
  248. Risk of Transmitting Cancer Through Blood Transfusion Minimal
  249. HPV Vaccine Protects Against Vulvar and Vaginal Cancers
  250. LHRH-Analogues Beneficial in Premenopausal Women With Hormone-Receptor-Positive Breas